{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:45:41Z","timestamp":1791549941630,"version":"4.3.4"},"reference-count":94,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-breast-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.clbc.2023.12.010","type":"journal-article","created":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T07:07:49Z","timestamp":1703574469000},"page":"292-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Update on Management of Ductal Carcinoma in Situ"],"prefix":"10.1016","volume":"24","author":[{"given":"Joanna T.","family":"Buchheit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schacht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4213-0933","authenticated-orcid":false,"given":"Swati A.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clbc.2023.12.010_bib0001","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.clbc.2023.12.010_bib0002","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","article-title":"Ductal carcinoma in situ: to treat or not to treat, that is the question","volume":"121","author":"van Seijen","year":"2019","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/j.clbc.2023.12.010_bib0003","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1002\/1097-0142(19951001)76:7<1197::AID-CNCR2820760715>3.0.CO;2-0","article-title":"Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy","volume":"76","author":"Page","year":"1995","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.clbc.2023.12.010_bib0004","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/cncr.20979","article-title":"Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study","volume":"103","author":"Collins","year":"2005","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.clbc.2023.12.010_bib0005","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/cncr.21069","article-title":"The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up","volume":"103","author":"Sanders","year":"2005","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.clbc.2023.12.010_bib0006","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.ejso.2021.10.030","article-title":"Advances and controversies in management of breast ductal carcinoma in situ (DCIS)","volume":"48","author":"Farante","year":"2022","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.clbc.2023.12.010_bib0007","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","article-title":"Breast cancer mortality after a diagnosis of ductal carcinoma in situ","volume":"1","author":"Narod","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clbc.2023.12.010_sbref0008","series-title":"Breast Cancer. Version 4.2023","year":"2023"},{"issue":"33","key":"10.1016\/j.clbc.2023.12.010_bib0009","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.1200\/JCO.19.01472","article-title":"Use of endocrine therapy for breast cancer risk reduction: ASCO clinical practice guideline update","volume":"37","author":"Visvanathan","year":"2019","journal-title":"J Clin Oncol"},{"issue":"10218","key":"10.1016\/j.clbc.2023.12.010_bib0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(19)32955-1","article-title":"Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial","volume":"395","author":"Cuzick","year":"2020","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.clbc.2023.12.010_bib0011","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343","volume":"31","author":"Hughes","year":"2013","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.clbc.2023.12.010_bib0012","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMoa040587","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer","volume":"351","author":"Hughes","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clbc.2023.12.010_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2023.113276","article-title":"Active surveillance versus treatment in low-risk DCIS: women's preferences in the LORD-trial","volume":"192","author":"Schmitz","year":"2023","journal-title":"Eur J Cancer"},{"issue":"16","key":"10.1016\/j.clbc.2023.12.010_bib0014","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","article-title":"Addressing overtreatment of screen detected DCIS; the LORIS trial","volume":"51","author":"Francis","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clbc.2023.12.010_bib0015","unstructured":"Iwata H. Single-arm confirmatory trial of endocrine therapy alone for estrogen receptor-positive, low-risk ductal carcinoma in situ of the breast (JCOG1505, LORETTA trial). Accessed 21 August 2023, https:\/\/center6.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000032260."},{"issue":"3","key":"10.1016\/j.clbc.2023.12.010_bib0016","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026797","article-title":"The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)","volume":"9","author":"Hwang","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.clbc.2023.12.010_bib0017","unstructured":"Bellon J. The PRECISION Trial (Profiling Early Breast Cancer for Radiotherapy Omission): A Phase II Study of Breast-Conserving Surgery Without Adjuvant Radiotherapy for Favorable-Risk Breast Cancer. Accessed 12 June 2023. https:\/\/beta.clinicaltrials.gov\/study\/NCT02653755."},{"issue":"11","key":"10.1016\/j.clbc.2023.12.010_bib0018","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1245\/s10434-021-09903-1","article-title":"The clinical utility of DCISionRT(R) on radiation therapy decision making in patients with ductal carcinoma in situ following breast-conserving surgery","volume":"28","author":"Shah","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"17","key":"10.1016\/j.clbc.2023.12.010_bib0019","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1200\/JCO.22.02900","article-title":"Randomized placebo controlled trial of low-dose tamoxifen to prevent recurrence in breast noninvasive neoplasia: a 10-year follow-up of TAM-01 study","volume":"41","author":"Lazzeroni","year":"2023","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.clbc.2023.12.010_bib0020","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1200\/JCO.19.00510","article-title":"Phase II single-arm study of preoperative letrozole for estrogen receptor-positive postmenopausal ductal carcinoma in situ: CALGB 40903 (Alliance)","volume":"38","author":"Hwang","year":"2020","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2023.12.010_bib0021","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1158\/1940-6207.CAPR-22-0388","article-title":"Phase II trial of nelipepimut-S peptide vaccine in women with ductal carcinoma in situ","volume":"16","author":"O'Shea","year":"2023","journal-title":"Cancer Prev Res (Phila)"},{"issue":"12","key":"10.1016\/j.clbc.2023.12.010_bib0022","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1158\/1078-0432.CCR-16-1924","article-title":"Dendritic cell vaccination enhances immune responses and induces regression of HER2(pos) DCIS independent of route: results of randomized selection design trial","volume":"23","author":"Lowenfeld","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.clbc.2023.12.010_bib0023","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1148\/radiology.172.1.2544922","article-title":"Clinically occult ductal carcinoma in situ detected with mammography: analysis of 100 cases with radiologic-pathologic correlation","volume":"172","author":"Stomper","year":"1989","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.clbc.2023.12.010_bib0024","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejrad.2004.11.019","article-title":"Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations","volume":"54","author":"Barreau","year":"2005","journal-title":"Eur J Radiol"},{"issue":"41","key":"10.1016\/j.clbc.2023.12.010_bib0025","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jncimonographs\/lgq037","article-title":"Imaging for the diagnosis and management of ductal carcinoma in situ","volume":"2010","author":"D'Orsi","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"6","key":"10.1016\/j.clbc.2023.12.010_bib0026","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.clinimag.2015.06.006","article-title":"Screening mammography-detected ductal carcinoma in situ: mammographic features based on breast cancer subtypes","volume":"39","author":"Kim","year":"2015","journal-title":"Clin Imaging"},{"issue":"6","key":"10.1016\/j.clbc.2023.12.010_bib0027","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.21037\/gs-20-428","article-title":"Ultrasonographic features of ductal carcinoma in situ: analysis of 219 lesions","volume":"9","author":"Li","year":"2020","journal-title":"Gland Surg"},{"issue":"1","key":"10.1016\/j.clbc.2023.12.010_bib0028","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jbi\/wbab088","article-title":"Recent trends in screening breast MRI","volume":"4","author":"Lee","year":"2022","journal-title":"J Breast Imaging"},{"issue":"24","key":"10.1016\/j.clbc.2023.12.010_bib0029","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1002\/cncr.33140","article-title":"Trends in screening breast magnetic resonance imaging use among US women, 2006 to 2016","volume":"126","author":"Wernli","year":"2020","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.clbc.2023.12.010_bib0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11606-017-4224-6","article-title":"Utilization of breast cancer screening with magnetic resonance imaging in community practice","volume":"33","author":"Hill","year":"2018","journal-title":"J Gen Intern Med"},{"issue":"3","key":"10.1016\/j.clbc.2023.12.010_bib0031","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2214\/AJR.07.3779","article-title":"Pure ductal carcinoma in situ: a range of MRI features","volume":"191","author":"Raza","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.clbc.2023.12.010_bib0032","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1148\/radiol.2019182947","article-title":"Breast MRI: state of the art","volume":"292","author":"Mann","year":"2019","journal-title":"Radiology"},{"issue":"22","key":"10.1016\/j.clbc.2023.12.010_bib0033","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1903986","article-title":"Supplemental MRI screening for women with extremely dense breast tissue","volume":"381","author":"Bakker","year":"2019","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.clbc.2023.12.010_bib0034","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/jnci\/94.20.1546","article-title":"Detection of ductal carcinoma in situ in women undergoing screening mammography","volume":"94","author":"Ernster","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.clbc.2023.12.010_bib0035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1470-2045(15)00446-5","article-title":"Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study","volume":"17","author":"Duffy","year":"2016","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2023.12.010_bib0036","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221785","article-title":"Supplemental breast cancer screening in women with dense breasts and negative mammography: a systematic review and meta-analysis","volume":"306","author":"Hussein","year":"2023","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.clbc.2023.12.010_bib0037","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.crad.2012.09.003","article-title":"Screening-detected calcified and non-calcified ductal carcinoma in situ: differences in the imaging and histopathological features","volume":"68","author":"Mun","year":"2013","journal-title":"Clin Radiol"},{"issue":"2","key":"10.1016\/j.clbc.2023.12.010_bib0038","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1148\/radiol.2020191535","article-title":"Surgical outcomes for ductal carcinoma in situ: impact of preoperative MRI","volume":"295","author":"Yoon","year":"2020","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.clbc.2023.12.010_bib0039","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jamaoncol.2018.6269","article-title":"Association of magnetic resonance imaging and a 12-gene expression assay with breast ductal carcinoma in situ treatment","volume":"5","author":"Lehman","year":"2019","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.12.010_bib0040","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1148\/radiol.2021204743","article-title":"Preoperative breast MRI for newly diagnosed ductal carcinoma in situ: imaging features and performance in a multicenter setting (ECOG-ACRIN E4112 trial)","volume":"301","author":"Chou","year":"2021","journal-title":"Radiology"},{"issue":"11","key":"10.1016\/j.clbc.2023.12.010_bib0041","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.29697","article-title":"Patient-reported testing burden of breast magnetic resonance imaging among women with ductal carcinoma in situ: an ancillary study of the ECOG-ACRIN cancer research group (E4112)","volume":"4","author":"Fazeli","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"22","key":"10.1016\/j.clbc.2023.12.010_bib0042","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1200\/JCO.2013.52.5386","article-title":"Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI","volume":"32","author":"Kuhl","year":"2014","journal-title":"J Clin Oncol"},{"issue":"11S","key":"10.1016\/j.clbc.2023.12.010_bib0043","doi-asserted-by":"crossref","first-page":"R74","DOI":"10.1016\/j.jacr.2016.09.031","article-title":"An abbreviated protocol for high-risk screening breast MRI saves time and resources","volume":"13","author":"Harvey","year":"2016","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.clbc.2023.12.010_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2019.108788","article-title":"Breast magnetic resonance imaging for estimation of the tumour extent in patients with pure ductal carcinoma in situ: Comparison between full diagnostic and abbreviated protocols","volume":"123","author":"Shiraishi","year":"2020","journal-title":"Eur J Radiol"},{"issue":"2","key":"10.1016\/j.clbc.2023.12.010_bib0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.diii.2016.08.013","article-title":"Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): A retrospective comparison in 66 breast lesions","volume":"98","author":"Li","year":"2017","journal-title":"Diagn Interv Imaging"},{"issue":"3","key":"10.1016\/j.clbc.2023.12.010_bib0046","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1148\/rg.2021200167","article-title":"Contrast-enhanced mammography: how does it work?","volume":"41","author":"Sensakovic","year":"2021","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.clbc.2023.12.010_bib0047","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40644-023-00526-1","article-title":"Contrast enhanced mammography: focus on frequently encountered benign and malignant diagnoses","volume":"23","author":"Yang","year":"2023","journal-title":"Cancer Imaging"},{"issue":"1","key":"10.1016\/j.clbc.2023.12.010_bib0048","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2214\/AJR.17.19265","article-title":"Contrast-enhanced mammography: a systematic guide to interpretation and reporting","volume":"212","author":"Perry","year":"2019","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.clbc.2023.12.010_bib0049","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s43055-021-00554-6","article-title":"Added value of contrast-enhanced spectral mammogram in assessment of suspicious microcalcification and grading of DCIS","volume":"52","author":"Shetat","year":"2021","journal-title":"Egypt J Radiol Nucl Med"},{"issue":"9","key":"10.1016\/j.clbc.2023.12.010_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162740","article-title":"Dual-energy contrast-enhanced spectral mammography: enhancement analysis on BI-RADS 4 non-mass microcalcifications in screened women","volume":"11","author":"Cheung","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.clbc.2023.12.010_bib0051","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1177\/0284185118822639","article-title":"Contrast-enhanced spectral mammography in the evaluation of breast suspicious calcifications: diagnostic accuracy and impact on surgical management","volume":"60","author":"Houben","year":"2019","journal-title":"Acta Radiol"},{"issue":"4","key":"10.1016\/j.clbc.2023.12.010_bib0052","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ejso.2017.12.007","article-title":"Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ","volume":"44","author":"Maxwell","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.clbc.2023.12.010_bib0053","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/jnci\/djy220","article-title":"Cancer outcomes in DCIS patients without locoregional treatment","volume":"111","author":"Ryser","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.clbc.2023.12.010_bib0054","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1002\/cam4.5071","article-title":"Exploration of the breast ductal carcinoma in situ signature and its prognostic implications","volume":"12","author":"Zhang","year":"2023","journal-title":"Cancer Med"},{"issue":"12","key":"10.1016\/j.clbc.2023.12.010_bib0055","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","article-title":"Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study","volume":"51","author":"Elshof","year":"2015","journal-title":"Eur J Cancer"},{"issue":"Suppl 3","key":"10.1016\/j.clbc.2023.12.010_bib0056","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1245\/s10434-017-6175-x","article-title":"Confusion over differences in registration and randomization criteria for the LORIS (Low-Risk DCIS) trial: a reply","volume":"24","author":"Pilewskie","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"Suppl 3","key":"10.1016\/j.clbc.2023.12.010_bib0057","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1245\/s10434-017-6174-y","article-title":"Confusion over differences in registration and randomization criteria for the LORIS (Low-Risk DCIS) trial","volume":"24","author":"Rea","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2023.12.010_bib0058","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10549-018-05082-y","article-title":"Significant inter- and intra-laboratory variation in grading of ductal carcinoma in situ of the breast: a nationwide study of 4901 patients in the Netherlands","volume":"174","author":"van Dooijeweert","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.clbc.2023.12.010_bib0059","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/cjp2.201","article-title":"Variability in grading of ductal carcinoma in situ among an international group of pathologists","volume":"7","author":"van Seijen","year":"2021","journal-title":"J Pathol Clin Res"},{"issue":"8","key":"10.1016\/j.clbc.2023.12.010_bib0060","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1093\/jjco\/hyab082","article-title":"Surgical upstaging rates in patients meeting the eligibility for active surveillance trials","volume":"51","author":"Iwamoto","year":"2021","journal-title":"Jpn J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.12.010_bib0061","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41523-022-00420-2","article-title":"Is conservative management of ductal carcinoma in situ risky?","volume":"8","author":"Zheng","year":"2022","journal-title":"NPJ Breast Cancer"},{"issue":"15_suppl","key":"10.1016\/j.clbc.2023.12.010_bib0062","doi-asserted-by":"crossref","first-page":"TPS603","DOI":"10.1200\/JCO.2019.37.15_suppl.TPS603","article-title":"The international collaboration of active surveillance trials for low-risk DCIS (LORIS, LORD, COMET, LORETTA)","volume":"37","author":"Kanbayashi","year":"2019","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.clbc.2023.12.010_bib0063","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1245\/s10434-019-07537-y","article-title":"Comparison of local recurrence risk estimates after breast-conserving surgery for DCIS: DCIS nomogram versus refined oncotype DX breast DCIS score","volume":"26","author":"Van Zee","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.clbc.2023.12.010_bib0064","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.ccell.2022.10.021","article-title":"Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts","volume":"40","author":"Strand","year":"2022","journal-title":"Cancer Cell"},{"issue":"32","key":"10.1016\/j.clbc.2023.12.010_bib0065","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1200\/JCO.2014.56.2595","article-title":"Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial","volume":"32","author":"Warnberg","year":"2014","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.clbc.2023.12.010_bib0066","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1080\/02841860600681569","article-title":"SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening","volume":"45","author":"Emdin","year":"2006","journal-title":"Acta Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2023.12.010_bib0067","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00520-016-3417-6","article-title":"Quality of life (QOL) and symptom burden (SB) in patients with breast cancer","volume":"25","author":"Hamer","year":"2017","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.clbc.2023.12.010_bib0068","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005633","article-title":"Long-term cardiovascular risk after radiotherapy in women with breast cancer","volume":"6","author":"Cheng","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.clbc.2023.12.010_bib0069","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jamaoncol.2018.6643","article-title":"Assessment of radiotherapy-associated angiosarcoma after breast cancer treatment in a Dutch population-based study","volume":"5","author":"Rombouts","year":"2019","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2023.12.010_bib0070","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1245\/s10434-019-08085-1","article-title":"Treatment and prognosis of radiation-associated breast angiosarcoma in a nationwide population","volume":"27","author":"Salminen","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2023.12.010_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.suronc.2022.101726","article-title":"Radiation-associated angiosarcoma of the breast: an international multicenter analysis","volume":"41","author":"Mergancova","year":"2022","journal-title":"Surg Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.12.010_bib0072","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ijrobp.2010.04.042","article-title":"Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline","volume":"81","author":"Smith","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.clbc.2023.12.010_bib0073","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ijrobp.2020.03.049","article-title":"Acute toxicity and quality of life of hypofractionated radiation therapy for breast cancer","volume":"107","author":"Arsenault","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"10.1016\/j.clbc.2023.12.010_bib0074","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jamaoncol.2016.6948","article-title":"Association of radiotherapy boost for ductal carcinoma in situ with local control after whole-breast radiotherapy","volume":"3","author":"Moran","year":"2017","journal-title":"JAMA Oncol"},{"issue":"10350","key":"10.1016\/j.clbc.2023.12.010_bib0075","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0140-6736(22)01246-6","article-title":"Radiation doses and fractionation schedules in non-low-risk ductal carcinoma in situ in the breast (BIG 3-07\/TROG 07.01): a randomised, factorial, multicentre, open-label, phase 3 study","volume":"400","author":"Chua","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2023.12.010_bib0076","unstructured":"ASTRO Targeting Cancer Care. ASTRO Guideline on Radiation Therapy for the Whole Breast. Accessed 13 September 2023. https:\/\/www.astro.org\/Patient-Care-and-Research\/Clinical-Practice-Statements\/Whole-Breast-Irradiation-GL."},{"issue":"1","key":"10.1016\/j.clbc.2023.12.010_bib0077","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/j.clbc.2021.05.016","article-title":"Has hypofractionated whole-breast radiation therapy become the standard of care in the United States? An updated report from national cancer database","volume":"22","author":"Kang","year":"2022","journal-title":"Clin Breast Cancer"},{"issue":"7","key":"10.1016\/j.clbc.2023.12.010_bib0078","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1200\/JCO.2014.57.9029","article-title":"RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation","volume":"33","author":"McCormick","year":"2015","journal-title":"J Clin Oncol"},{"issue":"32","key":"10.1016\/j.clbc.2023.12.010_bib0079","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1200\/JCO.21.01083","article-title":"Randomized phase III trial evaluating radiation following surgical excision for good-risk ductal carcinoma in situ: long-term report from NRG oncology\/RTOG 9804","volume":"39","author":"McCormick","year":"2021","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.clbc.2023.12.010_bib0080","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1158\/1078-0432.CCR-18-0842","article-title":"A biological signature for breast ductal carcinoma in situ to predict radiotherapy benefit and assess recurrence risk","volume":"24","author":"Bremer","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"15","key":"10.1016\/j.clbc.2023.12.010_bib0081","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1158\/1078-0432.CCR-19-1152","article-title":"Validation of a ductal carcinoma in situ biomarker profile for risk of recurrence after breast-conserving surgery with and without radiotherapy","volume":"26","author":"Weinmann","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2023.12.010_bib0082","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ebiom.2016.08.014","article-title":"SIAH and EGFR, two RAS pathway biomarkers, are highly prognostic in locally advanced and metastatic breast cancer","volume":"11","author":"van Reesema","year":"2016","journal-title":"EBioMedicine"},{"issue":"9169","key":"10.1016\/j.clbc.2023.12.010_bib0083","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(99)05036-9","article-title":"Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast And Bowel Project B-24 randomised controlled trial","volume":"353","author":"Fisher","year":"1999","journal-title":"Lancet"},{"issue":"9922","key":"10.1016\/j.clbc.2023.12.010_bib0084","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(13)62292-8","article-title":"Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial","volume":"383","author":"Cuzick","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clbc.2023.12.010_bib0085","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1470-2045(07)70385-6","article-title":"Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial","volume":"9","year":"2008","journal-title":"Lancet Oncol"},{"issue":"18","key":"10.1016\/j.clbc.2023.12.010_bib0086","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"10.1016\/j.clbc.2023.12.010_bib0087","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1200\/JCO.18.01779","article-title":"randomized placebo controlled trial of low-dose tamoxifen to prevent local and contralateral recurrence in breast intraepithelial neoplasia","volume":"37","author":"DeCensi","year":"2019","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1016\/j.clbc.2023.12.010_bib0088","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1200\/JCO.23.00455","article-title":"Endocrine therapy for primary and secondary prevention after diagnosis of high-risk breast lesions or preinvasive breast cancer","volume":"41","author":"Laws","year":"2023","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.clbc.2023.12.010_bib0089","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1245\/s10434-021-11169-6","article-title":"Evaluating the effects of a tissue selective estrogen complex (TSEC) in women with newly diagnosed ductal carcinoma in situ","volume":"29","author":"Verbus","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.clbc.2023.12.010_bib0090","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/GME.0b013e318252e46d","article-title":"Effects of bazedoxifene acetate with and without conjugated equine estrogens on the breast of postmenopausal monkeys","volume":"19","author":"Ethun","year":"2012","journal-title":"Menopause"},{"issue":"10","key":"10.1016\/j.clbc.2023.12.010_bib0091","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1022301","article-title":"Progressive loss of anti-HER2 CD4(+) T-helper type 1 response in breast tumorigenesis and the potential for immune restoration","volume":"4","author":"Datta","year":"2015","journal-title":"Oncoimmunology"},{"issue":"5","key":"10.1016\/j.clbc.2023.12.010_bib0092","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ccr.2007.10.017","article-title":"Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors","volume":"12","author":"Gauthier","year":"2007","journal-title":"Cancer Cell"},{"issue":"23","key":"10.1016\/j.clbc.2023.12.010_bib0093","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1200\/JCO.2009.26.8847","article-title":"Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ","volume":"28","author":"Rudloff","year":"2010","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.clbc.2023.12.010_bib0094","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/jnci\/djt067","article-title":"A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast","volume":"105","author":"Solin","year":"2013","journal-title":"J Natl Cancer Inst"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923003257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923003257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T16:36:00Z","timestamp":1742229360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820923003257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":94,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1526820923003257"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2023.12.010","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Update on Management of Ductal Carcinoma in Situ","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2023.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}